REFERENCES
1. Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, et al.
Effect of Total Laparoscopic Hysterectomy vs Total Abdominal
Hysterectomy on Disease-Free Survival Among Women With Stage I
Endometrial Cancer: A Randomized Clinical Trial. JAMA. 2017 Mar
28;317(12):1224–33.
2. Mourits MJE, Bijen CB, Arts HJ, ter Brugge HG, van der Sijde R,
Paulsen L, et al. Safety of laparoscopy versus laparotomy in early-stage
endometrial cancer: a randomised trial. Lancet Oncol. 2010
Aug;11(8):763–71.
3. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG).
Richtlijn Endometriumcarcinoom [Internet]. Endometriumcarcinoom.
[cited 2023 Aug 8]. Available from:
https://richtlijnendatabase.nl/richtlijn/endometriumcarcinoom/algemeen.html
4. Mettler L, Nikam YA. A comparative survey of various uterine
manipulators used in operative laparoscopy. Gynecol Surg. 2006
Dec;3(4):239–43.
5. van den Haak L, Alleblas C, Nieboer TE, Rhemrev JP, Jansen FW.
Efficacy and safety of uterine manipulators in laparoscopic surgery: a
review. Arch Gynecol Obstet. 2015 Nov;292(5):1003–11.
6. McCartney AJ, Obermair A. Total laparoscopic hysterectomy with a
transvaginal tube. J Am Assoc Gynecol Laparosc. 2004 Feb;11(1):79–82.
7. Machida H, Hom MS, Adams CL, Eckhardt SE, Garcia-Sayre J, Mikami M,
et al. Intrauterine Manipulator Use During Minimally Invasive
Hysterectomy and Risk of Lymphovascular Space Invasion in Endometrial
Cancer. Int J Gynecol Cancer. 2018 Feb;28(2):208–19.
8. Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ. High
incidence of positive peritoneal cytology in low-risk endometrial cancer
treated by laparoscopically assisted vaginal hysterectomy. Gynecol
Oncol. 2001 Mar;80(3):378–82.
9. Weinberg LE, Kunos CA, Zanotti KM. Lymphovascular space invasion
(LVSI) is an isolated poor prognostic factor for recurrence and survival
among women with intermediate- to high-risk early-stage endometrioid
endometrial cancer. Int J Gynecol Cancer. 2013 Oct;23(8):1438–45.
10. Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA. Positive
peritoneal cytology is an independent risk-factor in early stage
endometrial cancer. Gynecol Oncol. 2013 Jan;128(1):77–82.
11. Oliver-Perez MR, Padilla-Iserte P, Arencibia-Sanchez O,
Martin-Arriscado C, Muruzabal JC, Diaz-Feijóo B, et al. Lymphovascular
Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of
Recurrence and Predictors. A Multicentre Retrospective Cohort Study of
the Spain Gynecologic Oncology Group. Cancers (Basel). 2023 May
4;15(9):2612.
12. Meng Y, Liu Y, Lin S, Cao C, Wu P, Gao P, et al. The effects of
uterine manipulators in minimally invasive hysterectomy for endometrial
cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2020
Jul 1;46(7):1225–32.
13. Scutiero G, Vizzielli G, Taliento C, Bernardi G, Martinello R,
Cianci S, et al. Influence of uterine manipulator on oncological outcome
in minimally invasive surgery of endometrial cancer: A systematic review
and meta-analysis. Eur J Surg Oncol. 2022 Oct;48(10):2112–8.
14. Alletti SG, Perrone E, Fedele C, Cianci S, Pasciuto T, Chiantera V,
et al. A Multicentric Randomized Trial to Evaluate the ROle of Uterine
MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of
Early-Stage Endometrial Cancer: The ROMANHY Trial. Front Oncol. 2021 Sep
10;11:720894.
15. Padilla-Iserte P, Lago V, Tauste C, Díaz-Feijoo B, Gil-Moreno A,
Oliver R, et al. Impact of uterine manipulator on oncological outcome in
endometrial cancer surgery. Am J Obstet Gynecol. 2021 Jan
1;224(1):65.e1-65.e11.
16. Siegenthaler F, Johann S, Imboden S, Samartzis N, Ledermann-Liu H,
Sarlos D, et al. Prospective Multicenter Trial Assessing the Impact of
Positive Peritoneal Cytology Conversion on Oncological Outcome in
Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery
with the use of an Intrauterine Manipulator. Ann Surg Oncol. 2022 Dec
1;29(13):8320–33.
17. Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total
laparoscopic hysterectomy for endometrial cancer: patterns of recurrence
and survival. Gynecol Oncol. 2004 Mar 1;92(3):789–93.
18. van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van Leeuwen
FE. Cancer incidence in The Netherlands in 1989 and 1990: first results
of the nationwide Netherlands cancer registry. Coordinating Committee
for Regional Cancer Registries. Eur J Cancer. 1995 Oct;31A(11):1822–9.
19. Casparie M, Tiebosch ATMG, Burger G, Blauwgeers H, van de Pol A, van
Krieken JHJM, et al. Pathology Databanking and Biobanking in The
Netherlands, a Central Role for PALGA, the Nationwide Histopathology and
Cytopathology Data Network and Archive. Cell Oncol. 2007;29(1):19–24.
20. Pecorelli S. Revised FIGO staging for carcinoma of the vulva,
cervix, and endometrium. Int J Gynaecol Obstet. 2009 May;105(2):103–4.
21. Legge F, Restaino S, Leone L, Carone V, Ronsini C, Di Fiore GLM, et
al. Clinical outcome of recurrent endometrial cancer: analysis of
post-relapse survival by pattern of recurrence and secondary treatment.
Int J Gynecol Cancer. 2020 Feb;30(2):193–200.
22. Siegenthaler F, Lindemann K, Epstein E, Rau TT, Nastic D, Ghaderi M,
et al. Time to first recurrence, pattern of recurrence, and survival
after recurrence in endometrial cancer according to the molecular
classification. Gynecol Oncol. 2022 May 1;165(2):230–8.
23. Tinelli R, Cicinelli E, Tinelli A, Bettocchi S, Angioni S, Litta P.
Laparoscopic treatment of early-stage endometrial cancer with and
without uterine manipulator: Our experience and review of literature.
Surg Oncol. 2016 Jun;25(2):98–103.
24. Uccella S, Bonzini M, Malzoni M, Fanfani F, Palomba S, Aletti G, et
al. The effect of a uterine manipulator on the recurrence and mortality
of endometrial cancer: a multi-centric study by the Italian Society of
Gynecological Endoscopy. Am J Obstet Gynecol. 2017
Jun;216(6):592.e1-592.e11.
25. Lee M, Kim Y, Kim S, Kim S, Kim J, Nam E. Effects of Uterine
Manipulation on Surgical Outcomes in Laparoscopic Management of
Endometrial Cancer A Prospective Randomized Clinical Trial. Int J
Gynaecol Cancer. 2012 Dec 20;23.
26. Polyzos NP, Mauri D, Tsioras S, Messini CI, Valachis A, Messinis IE.
Intraperitoneal dissemination of endometrial cancer cells after
hysteroscopy: a systematic review and meta-analysis. Int J Gynecol
Cancer. 2010 Feb;20(2):261–7.
27. Du Y, Xu Y, Qin Z, Sun L, Chen Y, Han L, et al. The Oncology Safety
of Diagnostic Hysteroscopy in Early-Stage Endometrial Cancer: A
Systematic Review and Meta-Analysis. Front Oncol. 2021;11:742761.
28. Zhou H, Lai KF, Xiang Q, Xu Y, Zhang QW, Hu C, et al. Oncological
Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II
Endometrial Cancer: A Multicenter Retrospective Cohort Study. Front
Oncol. 2022;12:918693.
29. Chang YN, Zhang Y, Wang YJ, Wang LP, Duan H. Effect of hysteroscopy
on the peritoneal dissemination of endometrial cancer cells: a
meta-analysis. Fertil Steril. 2011 Oct;96(4):957–61.
30. Reijntjes B, van Suijlichem M, Woolderink JM, Bongers MY,
Reesink-Peters N, Paulsen L, et al. Recurrence and survival after
laparoscopy versus laparotomy without lymphadenectomy in early-stage
endometrial cancer: Long-term outcomes of a randomised trial. Gynecol
Oncol. 2022 Feb;164(2):265–70.